View of Real-world data on the efficacy and safety of ibrutinib and venetoclax in patients with chronic lymphocytic leukemia, a single-center experience

Return to Issue Details Real-world data on the efficacy and safety of ibrutinib and venetoclax in patients with chronic lymphocytic leukemia, a single-center experience Download Download PDF